ArticlePolymers2026
Quaternary Ammonium Salt-Functionalized PA6-Based Elastomer as an Efficient Antistatic Additive for Polypropylene.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Polymeric antistatic additives offer improved resistance to migration compared with low-molecular-weight agents, but high loadings are generally required to establish effective charge-dissipation pathways in nonpolar polypropylene (PP). Herein, a series of quaternary ammonium salt-functionalized polyamide 6/polyethylene glycol elastomers (QASPA6PEG) was synthesized by melt copolymerization and used as multifunctional antistatic additives for PP. Increasing the nominal QAS content decreased the surface resistivity of the elastomers from 3.24 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.